/EMBC
Embecta Corp.
EMBC • NASDAQEMBC • NASDAQ • Healthcare
$8.81-2.11%-0.19
$8.81-2.11%(-0.19)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
100Bullish
Risk
77Low Risk
Momentum
6Negative
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
62.9%▼2.0pp
Revenue after COGS
Operating
30.5%▲15.0pp
After operating expenses
Net
8.8%▲1.9pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
8.6
Price vs earnings
EV/EBITDA
6.9
Enterprise value
FCF Yield
22.2%
Cash generation
Earnings Yield
11.6%
Inverse of P/E
Capital Efficiency
11
GoAI Quality ScoreFair
ROEReturn on Equity
-14.7%Weak
ROAReturn on Assets
8.7%Strong
ROICReturn on Invested Capital
27.4%Strong
Financial Health
Current RatioHealthy
2.41
Short-term solvency (>1.5)
Net Debt / EBITDAHigh
4.09x
Debt repayment capacity (<3x)
Income QualityStrong
2.01
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.08B | $1.12B | $1.12B | $1.13B | $1.17B |
| Gross Profit | $679.50M | $728.90M | $749.90M | $774.90M | $800.00M |
| Gross Margin | 62.9% | 64.9% | 66.9% | 68.6% | 68.7% |
| Operating Income | $329.30M | $174.20M | $229.60M | $378.10M | $492.00M |
| Net Income | $95.40M | $78.30M | $70.40M | $223.60M | $414.80M |
| Net Margin | 8.8% | 7.0% | 6.3% | 19.8% | 35.6% |
| EPS | $1.64 | $1.36 | $1.23 | $3.92 | $7.31 |
Average Price Target
$22.50▲ 155.4% Upside
Past 12 Months
12 Month Forecast
Based on 27 Wall Street analysts offering 12 month price targets for Embecta Corp., the average price target is $22.50, with a high forecast of $25.00 and a low forecast of $20.00. The average price target represents a 155.4% increase from the current price of $8.81.
Highest
$25.00
Average
$22.50
Lowest
$20.00
Rating Distribution
Strong Buy
0
0%
Buy
1
25%
Hold
1
25%
Sell
2
50%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
BTIG● Maintain
Buy
2026-02-06BTIG● Maintain
Buy
2025-09-05Mizuho● Maintain
Neutral
2025-07-16Mizuho● Maintain
Neutral
2025-05-23BTIG▲ Upgrade
Neutral→Buy
2024-11-27Morgan Stanley● Maintain
Underweight
2024-07-15Morgan Stanley● Maintain
Underweight
2024-05-10Morgan Stanley● Maintain
Underweight
2023-11-22Morgan Stanley● Maintain
Underweight
2023-10-18Morgan Stanley● Maintain
Underweight
2023-10-17Earnings History & Surprises
BEAT RATE
93%
Last 15 quarters
AVG SURPRISE
+41.9%
EPS vs Estimate
BEATS / MISSES
14/1
Last 15 quarters
LATEST EPS
$0.71
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
+5.8%
$0.71 vs $0.67
Q4 '25
-28.6%
$0.50 vs $0.70
Q3 '25
+146.2%
$1.12 vs $0.46
Q2 '25
+6.1%
$0.70 vs $0.66
Q1 '25
+44.4%
$0.65 vs $0.45
Q4 '24
+25.0%
$0.45 vs $0.36
Q3 '24
+54.2%
$0.74 vs $0.48
Q2 '24
+55.8%
$0.67 vs $0.43
Q1 '24
+35.6%
$0.61 vs $0.45
Q4 '23
+40.5%
$0.59 vs $0.42
Q3 '23
+50.0%
$0.69 vs $0.46
Q2 '23
+50.0%
$0.75 vs $0.50
No investor questions available.
Latest News
No news available